Authors:
Holvoet, P
Mertens, A
Verhamme, P
Bogaerts, K
Beyens, G
Verhaeghe, R
Collen, D
Muls, E
Van de Werf, F
Citation: P. Holvoet et al., Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease, ART THROM V, 21(5), 2001, pp. 844-848
Authors:
Hulens, M
Vansant, G
Lysens, R
Claessens, AL
Muls, E
Brumagne, S
Citation: M. Hulens et al., Study of differences in peripheral muscle strength of lean versus obese women: an allometric approach, INT J OBES, 25(5), 2001, pp. 676-681
Authors:
Muls, E
Kolanowski, J
Scheen, A
Van Gaal, L
Citation: E. Muls et al., The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study, INT J OBES, 25(11), 2001, pp. 1713-1721
Authors:
Van Leuven, F
Thiry, E
Lambrechts, M
Stas, L
Boon, T
Bruynseels, K
Muls, E
Descamps, O
Citation: F. Van Leuven et al., Sequencing of the coding exons of the LRP1 and LDLR genes on individual DNA samples reveals novel mutations in both genes, ATHEROSCLER, 154(3), 2001, pp. 567-577
Citation: G. Vansant et al., The effect of atorvastatin on postprandial lipaemia in overweight or obesewomen homozygous for apo E3, ACT CARDIOL, 56(3), 2001, pp. 149-154
Citation: E. Muls et al., The efficacy of atorvastatin in treating patients with hypercholesterolaemia to target LDL-cholesterol goals: the LIPI-GOAL trial, ACT CARDIOL, 56(2), 2001, pp. 109-114
Authors:
Muls, E
De Backer, G
De Bacquer, D
Brohet, M
Heller, F
Citation: E. Muls et al., LIPI-WATCH, a Belgian/Luxembourg survey on achievement of European Atherosclerosis Society lipid goals, CLIN DRUG I, 19(3), 2000, pp. 219-229
Authors:
Moens, G
Van Gaal, L
Muls, E
Viaene, B
Jacques, P
Citation: G. Moens et al., Body mass index and health among the working population - Epidemiologic data from Belgium, EUR J PUB H, 9(2), 1999, pp. 119-123